An Evolution in Switching Therapy for Psoriasis Patients Who Fail to Meet Treatment Goals

Dermatologic Therapy - United Kingdom
doi 10.1111/dth.12267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Photodynamic Therapy in the Complex Treatment of Patients With Psoriasis

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2017English

Patients With Del(5q) MDS Who Fail to Achieve Sustained Erythroid or Cytogenetic Remission After Treatment With Lenalidomide Have an Increased Risk for Clonal Evolution and AML Progression

Annals of Hematology
MedicineHematology
2009English

Biologic Therapy Adherence, Discontinuation, Switching, and Restarting Among Patients With Psoriasis in the US Medicare Population

Journal of the American Academy of Dermatology
Dermatology
2016English

Systemic Therapy of Psoriasis in Diabetic Patients

Global Dermatology
2015English

Clinical Goals and Barriers to Effective Psoriasis Care

Dermatology and Therapy
Dermatology
2018English

Complex Metabolic Therapy in Patients With Psoriasis

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2018English

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Critical Gaps in Laboratory Leadership to Meet Global Health Security Goals

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2017English

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

JAMA Dermatology
DermatologyMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy